Cannabis stocks soared on Friday following news that U.S. president Donald Trump is expected to sign an executive order as soon as Monday that would ultimately ease federal restrictions on marijuana. The order would essentially reclassify marijuana from a Schedule I substance to Schedule III under the federal Controlled Substances Act.
July 2025 proved to be a compelling month for ETF investors, marked by a return to risk-on sentiment in some areas of the market, even as broader economic signals remained mixed. U.S. stocks saw a strong 2.2% rally, offsetting a decline in international markets.
Amplify's CNBS ETF has shifted focus to American cannabis and hemp, making it a better option than MSOS due to its more diversified structure. CNBS's portfolio is less concentrated in a few stocks compared to MSOS, reducing risk and offering better potential for long-term performance. Risks include 280E taxation remaining, CNBS's smaller size, and limited liquidity, but Tim Seymour's active management is a positive factor.